{"id":"https://openalex.org/W3136677013","doi":"https://doi.org/10.1615/critrevimmunol.2021037614","title":"Could Harnessing Natural Killer Cell Activity Be a Promising Therapy for Prostate Cancer?","display_name":"Could Harnessing Natural Killer Cell Activity Be a Promising Therapy for Prostate Cancer?","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3136677013","doi":"https://doi.org/10.1615/critrevimmunol.2021037614","mag":"3136677013","pmid":"https://pubmed.ncbi.nlm.nih.gov/34348004","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8966398"},"language":"en","primary_location":{"id":"doi:10.1615/critrevimmunol.2021037614","doi":"https://doi.org/10.1615/critrevimmunol.2021037614","is_oa":false,"landing_page_url":"https://doi.org/10.1615/critrevimmunol.2021037614","pdf_url":null,"source":{"id":"https://openalex.org/S73794665","display_name":"Critical Reviews in Immunology","issn_l":"0197-3355","issn":["0197-3355","1040-8401","2162-6472"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315730","host_organization_name":"Begell House","host_organization_lineage":["https://openalex.org/P4310315730"],"host_organization_lineage_names":["Begell House"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8966398","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101919644","display_name":"Jennifer D. Wu","orcid":"https://orcid.org/0000-0002-8925-268X","observed_orcids":["https://orcid.org/0000-0002-8925-268X"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jennifer Wu","raw_affiliation_strings":["Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA","institution_ids":["https://openalex.org/I111979921"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101919644"],"corresponding_institution_ids":["https://openalex.org/I111979921"],"apc_list":null,"apc_paid":null,"fwci":0.6519,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.60610939,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"41","issue":"2","first_page":"101","last_page":"106"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9950000047683716},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/nk-cell-therapy","display_name":"NK cell therapy","score":0.7689999938011169},{"id":"https://openalex.org/keywords/cold-tumors","display_name":"cold tumors","score":0.7860000133514404},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.6460000276565552},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7300000190734863},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.7630000114440918}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6186352968215942},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5458659529685974},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5157189965248108},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.5101709365844727},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.501716136932373},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4848867356777191},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48292943835258484},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.4651547074317932},{"id":"https://openalex.org/C2778102761","wikidata":"https://www.wikidata.org/wiki/Q332181","display_name":"Natural killer cell","level":4,"score":0.4542338252067566},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4417755603790283},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3940039873123169},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37535804510116577},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.2885863482952118},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14522409439086914},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14302441477775574},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07367730140686035},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1615/critrevimmunol.2021037614","doi":"https://doi.org/10.1615/critrevimmunol.2021037614","is_oa":false,"landing_page_url":"https://doi.org/10.1615/critrevimmunol.2021037614","pdf_url":null,"source":{"id":"https://openalex.org/S73794665","display_name":"Critical Reviews in Immunology","issn_l":"0197-3355","issn":["0197-3355","1040-8401","2162-6472"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315730","host_organization_name":"Begell House","host_organization_lineage":["https://openalex.org/P4310315730"],"host_organization_lineage_names":["Begell House"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Immunology","raw_type":"journal-article"},{"id":"pmid:34348004","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34348004","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical reviews in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8966398","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8966398","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Crit Rev Immunol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:8966398","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8966398","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Crit Rev Immunol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3202261450","display_name":"Target MIC shedding to revive anti-tumor immunity","funder_award_id":"R01CA204021","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4841086150","display_name":"NKG2D superagonist co-stimulation to enhance adaptive immunotherapy of cancer","funder_award_id":"R01CA208246","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5561180324","display_name":"Tumor immune and glycan biomarkers for progressive prostate cancer","funder_award_id":"R01CA212409","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1671560425","https://openalex.org/W1972814015","https://openalex.org/W1978942158","https://openalex.org/W1979371667","https://openalex.org/W1979811833","https://openalex.org/W2051410494","https://openalex.org/W2060666846","https://openalex.org/W2062135418","https://openalex.org/W2085462535","https://openalex.org/W2103637402","https://openalex.org/W2118991367","https://openalex.org/W2185042879","https://openalex.org/W2189192330","https://openalex.org/W2329107713","https://openalex.org/W2332619013","https://openalex.org/W2463867199","https://openalex.org/W2516362774","https://openalex.org/W2531934133","https://openalex.org/W2580641909","https://openalex.org/W2589172342","https://openalex.org/W2600889491","https://openalex.org/W2606806612","https://openalex.org/W2615520798","https://openalex.org/W2741550370","https://openalex.org/W2748446253","https://openalex.org/W2753621408","https://openalex.org/W2754054357","https://openalex.org/W2756181170","https://openalex.org/W2808503433","https://openalex.org/W2903848939","https://openalex.org/W2951071083","https://openalex.org/W2956054465","https://openalex.org/W2967552519","https://openalex.org/W2969924938","https://openalex.org/W2981185653","https://openalex.org/W2982970399","https://openalex.org/W2999032994","https://openalex.org/W3014592760","https://openalex.org/W3025139618","https://openalex.org/W3038718086","https://openalex.org/W3087526274"],"related_works":["https://openalex.org/W7221115934","https://openalex.org/W4248596273","https://openalex.org/W2590255260","https://openalex.org/W2082015953","https://openalex.org/W2066736600","https://openalex.org/W1671560425","https://openalex.org/W4393088665","https://openalex.org/W4324136791","https://openalex.org/W2326114696","https://openalex.org/W3175100275"],"abstract_inverted_index":{"Harnessing":[0],"natural":[1],"killer":[2],"(NK)":[3],"cell":[4,34,75,78,107,131,143],"activity,":[5,76],"either":[6],"endogenous":[7],"NK":[8,33,77,106,130,142],"or":[9],"NK-cell-based":[10,119],"therapy,":[11],"is":[12,53,112],"in":[13,133],"the":[14,27,43,97,126],"forefront":[15],"development":[16],"for":[17,109,145],"many":[18],"tumor":[19,59],"types.":[20],"There":[21],"are":[22],"compelling":[23],"clinical":[24,120,127],"evidence":[25],"demonstrating":[26],"significant":[28],"relevance":[29],"of":[30,32,129],"loss":[31],"activity":[35,108,132,144],"with":[36,115],"prostate":[37],"cancer":[38],"(PCa)":[39],"disease":[40],"progression":[41],"to":[42,66,71,88,94],"lethal":[44],"phenotype,":[45],"metastatic":[46,135],"castration-resistant":[47],"PCa":[48,136],"(mCRPC).":[49],"Given":[50],"that":[51],"mCRPC":[52,91,99,111],"generally":[54],"regarded":[55],"as":[56],"a":[57,83],"\"cold\"":[58],"and":[60,92,137],"has":[61],"only":[62,87,116],"elicited":[63],"marginal":[64],"response":[65],"immune":[67],"checkpoint":[68],"blockade":[69],"therapy":[70,80],"revive":[72],"CD8":[73],"T":[74],"targeted":[79],"may":[81],"present":[82,125],"viable":[84],"opportunity":[85],"not":[86],"directly":[89],"target":[90],"also":[93],"\"fire":[95],"up\"":[96],"cold":[98],"tumor.":[100],"However,":[101],"current":[102],"efforts":[103],"on":[104,140],"harnessing":[105,141],"treating":[110,146],"very":[113],"limited":[114],"one":[117],"open":[118],"trial.":[121],"This":[122],"minireview":[123],"will":[124],"significance":[128],"controlling":[134],"provide":[138],"perspectives":[139],"mCRPC.":[147]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-03-29T00:00:00"}